Key points are not available for this paper at this time.
Design
Review
Supports prioritizing novel TAVR designs with expanding indications; leaves open validation of specific innovations in prospective trials.
The expansion of TAVR over SAVR and to new indications seems more promising than ever. With new challenges to come, new TAV design approaches, and materials used, are expected to emerge, and novel testing/modeling methods to be developed.
No takes yet. Share an insight, caveat, or question.
Rotman et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: